Asset Sadhu
Funds/Sectoral / Thematic/Tata India Pharma & Heathcare Fund

Tata India Pharma & Heathcare Fund

Tata Mutual Fund·Sectoral / Thematic·vs Nifty 500 TRI

The fund maintains a tight, conviction-driven thesis on pharma and healthcare with over half the portfolio in pharmaceuticals while strategically balancing with high-quality hospital chains. The top-heavy concentration—over half in ten names—reflects the manager's selective approach toward sector leaders rather than diversified exposure. The exit of Krishna Institute signals tactical rebalancing, possibly trimming smaller healthcare players to reinforce positions in proven operators like Sun Pharma and Abbott, suggesting confidence in large-cap defensive positioning within an expanding healthcare narrative.

Portfolio analysis · April 2026

NAV & Returns

PlanNAV1M3M6M1Y3Y CAGR5Y CAGR
Direct Growth₹36.5437——————
Regular Growth₹31.0484+7.60%+5.38%+0.44%+5.70%+23.23%+13.73%
Returns above 1Y are CAGR. Direct plan rows highlighted. NAV from AMFI.

Portfolio Metrics(latest month)

Holdings
36
Top 5 Weight
31.78%
Top 10 Weight
52.60%
Active Share
—
Large Cap
35.50%
Gini
0.381

What Changed2026-03-31 → 2026-04-30

Holdings: 40 → 39+0 added−1 removed19 weight shifts ≥ 0.1%
StockWeight
No new entries this month

Full Holdings

#Holding% to NAV
1
SUN PHARMACEUTICAL INDUSTRIES LTD
INE044A01036
9.87%
2
DIVI LABORATORIES LTD
INE361B01024
5.92%
3
HEALTHCARE GLOBAL ENTERPRISES LTD
INE075I01017
5.45%
4
ABBOTT INDIA LTD
INE358A01014
5.37%
5
MAX HEALTHCARE INSTITUTE LTD
INE027H01010
5.17%
6
CIPLA LTD
INE059A01026
5.07%
7
RAINBOW CHILDRENS MEDICARE LTD
INE961O01016
4.23%
8
APOLLO HOSPITALS ENTERPRISE LTD
INE437A01024
4.06%
9
MANKIND PHARMA LTD
INE634S01028
3.73%
10
DR REDDYS LABORATORIES LTD
INE089A01031
3.73%
11
FORTIS HEALTHCARE LTD
INE061F01013
3.55%
12
BAYER CROPSCIENCE LTD
INE462A01022
3.34%
13
METROPOLIS HEALTHCARE LTD
INE112L01020
3.07%
14
SYNGENE INTERNATIONAL LTD
INE398R01022
2.94%
15
LUPIN LTD
INE326A01037
2.94%
16
SAI LIFE SCIENCES LTD
INE570L01029
2.63%
17
DR. LAL PATH LABS LTD
INE600L01024
2.60%
18
ALKEM LABORATORIES LTD
INE540L01014
2.49%
19
GLAXOSMITHKLINE PHARMACEUTICALS LTD
INE159A01016
2.44%
20
NEULAND LABORATORIES LTD
INE794A01010
2.41%

Sector Allocation

Pharmaceuticals & Biotechnology58.7%
Healthcare Services35.0%
Fertilizers & Agrochemicals4.5%
Chemicals & Petrochemicals0.7%
Insurance0.7%

Top 10 sectors by % to NAV. Excludes derivatives.